Nhung Thi Hong Dinh

Nhung Thi Hong Dinh

Auto-generated profile, based on publicly available information

Nhung Thi Hong Dinh

Vinmec Research Institute of Stem Cell and Gene Technology College of Health Sciences VinUniversity Vinhomes Ocean Park Hanoi Vietnam

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2025 in Medcomm
Verified
Journal Article
Open access
VHVan T. Hoang
Van T. Hoang
QNQuyen Thi Nguyen
Quyen Thi Nguyen
TPTrang Thi Kieu Phan
Trang Thi Kieu Phan
TPTrang H. Pham
Trang H. Pham
NDNhung Thi Hong Dinh
Nhung Thi Hong Dinh
LTLiem Nguyen Thanh
Liem Nguyen Thanh
From the pioneering days of cell therapy to the achievement of bioprinting organs, tissue engineering, and regenerative medicine have seen tremendous technological advancements, offering solutions for restoring damaged tissues and organs. However, only a few products and technologies have received United States Food and Drug Administration approval. This review highlights significant progress in cell therapy, extracellular vesicle‐based therapy, and tissue engineering. Hematopoietic stem cell transplantation is a powerful tool for treating many diseases, especially hematological malignancies. Mesenchymal stem cells have been extensively studied. The discovery of induced pluripotent stem cells has revolutionized disease modeling and regenerative applications, paving the way for personalized medicine. Gene therapy represents an innovative approach to the treatment of genetic disorders. Additionally, extracellular vesicle‐based therapies have emerged as rising stars, offering promising solutions in diagnostics, cell‐free therapeutics, drug delivery, and targeted therapy. Advances in tissue engineering enable complex tissue constructs, further transforming the field. Despite these advancements, many technical, ethical, and regulatory challenges remain. This review addresses the current bottlenecks, emphasizing novel technologies and interdisciplinary research to overcome these hurdles. Standardizing practices and conducting clinical trials will balance innovation and regulation, improving patient outcomes and quality of life.

1 September 2017 in Annals of Translational Medicine
Verified
Journal Article
Open access
PDF file
LLLieu Thi Le
Lieu Thi Le
NDNhung Thi Hong Dinh
Nhung Thi Hong Dinh
MHMoc Thi Thanh Hoang
Moc Thi Thanh Hoang
NTNga Thi Tran
Nga Thi Tran
LALan Thuy An
Lan Thuy An
HLHai Thanh Le
Hai Thanh Le
Background: Pericentric inversion of chromosome 9 [inv(9)] is one of the most common human chromosomal variations. The aim of this study was to detect inv(9) from karyotype in children and its clinical correlation with birth defects. Methods: The chromosome analysis using G-banding was carried out in 8,869 suspected children with congenital abnormalities at Children’s Hospital Central from 2013 to May 2017. All of their clinical data will be reviewed. Results: Out of 8,869 cases, 2,361 chromosomal aberration cases were detected (26.6%). Chromosomal polymorphisms were detected in 267 patients (3%). In 267 patients with chromosomal polymorphisms, the most common of chromosome variation was inv(9), found in 60 patients (22.5%). Nine patients with inv(9) have other chromosomal abnormalities. Various congenital anomalies in patients with inv(9) consist of malformation, dysmorphic face, cerebral palsy, congenital heart defect, esophageal shrinkage, urogenital anomalies, inguinal hernia, hypospadias, and malformed anus. Conclusions: The inv(9) has been regarded as a normal variant in human population without phenotypic consequence. However, inv(9) would be expected to be associated with congenital anomalies in children. Many reports indicated that inv(9) has been associated with infertility, recurrent pregnancy loss. Few studies suspected that inv(9) is related to cancer such as ovarian cancers, acute leukemia, chronic myeloid leukemia. The parental chromosome analysis and genetic counseling are essential for children with inv(9).